Clinical Significance of Bone Marrow Blast Percentage in Patients With Myelofibrosis and the Effect of Ruxolitinib Therapy-Reference-Cited by-同舟云学术

Clinical Significance of Bone Marrow Blast Percentage in Patients With Myelofibrosis and the Effect of Ruxolitinib Therapy

Published:2021-05 Issue:5 Volume:21 Page:318-327.e6
ISSN:2152-2650
Container-title:Clinical Lymphoma Myeloma and Leukemia
language:en
Short-container-title:Clinical Lymphoma Myeloma and Leukemia

Author:

Masarova Lucia^ORCID,Bose Prithviraj,Pemmaraju Naveen,Daver Naval,Zhou Lingsha^ORCID,Pierce Sherry^ORCID,Kantarjian Hagop,Estrov Zeev,Verstovsek Srdan

Funder

National Cancer Institute

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference21 articles.

1. Guideline for the diagnosis and management of myelofibrosis;Reilly;Br J Haematol,2012

2. New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and Treatment;Cervantes;Blood,2009

3. A dynamic prognostic model to predict survival in primary myelofibrosis: a study by the IWG-MRT (International Working Group for Myeloproliferative Neoplasms Research and Treatment);Passamonti;Blood,2010

4. Dynamic International Prognostic Scoring System (DIPSS) predicts progression to acute myeloid leukemia in primary myelofibrosis;Passamonti;Blood,2010

5. Prognostic model to identify patients with myelofibrosis at the highest risk of transformation to acute myeloid leukemia;Quintas-Cardama;Clin Lymphoma Myeloma Leuk,2013

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic and Predictive Models in Myelofibrosis;Current Hematologic Malignancy Reports;2024-08-24

2. Advances in Microflow Cytometry-Based Molecular Detection Methods for Improved Future MDS Cancer Diagnosis;Current Issues in Molecular Biology;2024-07-26

3. Myelofibrosis: Current unmet needs, emerging treatments, and future perspectives;Cancer;2024-02-19

4. SOHO State of the Art Updates and Next Questions | Accelerated Phase of MPN: What It Is and What to Do About It;Clinical Lymphoma Myeloma and Leukemia;2023-05

5. Thrombocytopenia in Patients With Myelofibrosis: A Practical Management Guide;Clinical Lymphoma Myeloma and Leukemia;2022-12